Rgenta Therapeutics

Rgenta Shows Early ACC Response Data for RGT-61159

WOBURN, Massachusetts, May 21, 2026 Rgenta Therapeutics announced positive preliminary results from its ongoing Phase 1a/b clinical trial evaluating...

By cGxPwire Editor
May 23, 2026

We work Hard to get you posted with latest updates

Unwrap our new Directory

Rgenta Therapeutics

Rgenta Shows Early ACC Response Data for RGT-61159